Comparison of dapagliflozin 10 mg versus empagliflozin 10 mg in heart failure patients without type 2 diabetes mellitus on top of triple guideline-directed medical therapy

---

ÇÖLLÜOĞLU İ. T., ŞAHİN A., ÇELİK A., YILMAZ M. B., URAL D., NALBANTGİL S., ...More

Heart Failure 2025, Belgrade, Serbia, 17 - 20 May 2025, vol.27, pp.211, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 27
• City: Belgrade
• Country: Serbia
• Page Numbers: pp.211
• Dokuz Eylül University Affiliated: Yes